SAN ANTONIO — Treatment of numerous chronic pain conditions requires prolonged opioid administration, which is associated with numerous adverse effects. This has prompted identification of alternative ...
Vyteris LidoSite was approved by the FDA for relief of needle-stick pain.Vyteris Holdings (Nevada), Inc. (OTC BB:VYHN.OB) , the parent company of drug-delivery technology firm Vyteris Inc. of Fair ...
Credit: Alvogen, Inc. Fentanyl is an opioid agonist indicated for the management of severe or persistent pain in opioid-tolerant patients. At this time, Alvogen Inc has received 1 serious adverse ...
Bioson Pharmaceutical announced on the 30th that it will begin joint development with iCure, a company specializing in patch-type drug development, to develop the non-narcotic analgesic Opiranserin ...
Do not use a fentanyl transdermal system if the pouch seal is broken or the patch is cut, damaged, or changed in any way. Avoid exposing the fentanyl transdermal system application site and ...
Purpose: The efficacy and safety of fentanyl hydrochloride patient-controlled trans-dermal system (PCTS) for management of acute postoperative pain are discussed. Summary: Fentanyl hydrochloride PCTS ...
The transdermal patches market is further segmented based on the patch type, adhesive type, application, distribution channel, end-user, and region. The Drug-In-Adhesives segment is expected to ...
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Aricept ® Patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results